Trademark Attorney / Law Firm
Christopher Sappenfield – Trademark Portfolio
Christopher Sappenfield has 10 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 trademarks are successfully registered — a 43% registration rate, with an additional 3 applications currently pending. The strongest areas of practice include Class 21 (Housewares) and Class 10 (Medical Apparatus). Filing activity has been recorded from 2023 through 2026, spanning 4 years.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Christopher Sappenfield's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademark applications has Christopher Sappenfield filed?
Christopher Sappenfield has filed 10 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered, 3 pending, 4 abandoned.
What trademark classes does Christopher Sappenfield specialize in?
Christopher Sappenfield has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 21 (Housewares), Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
How long has Christopher Sappenfield been filing trademarks?
Christopher Sappenfield's trademark filing history with the USPTO spans from 2023 to 2026, covering 3 years of trademark practice. During this period, Christopher Sappenfield has handled 10 trademark applications.
What is Christopher Sappenfield's trademark registration success rate?
Christopher Sappenfield has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.